Armitage: “I am doing what I can” to keep Kappos at USPTO

Managing IP is part of Legal Benchmarking Limited, 1-2 Paris Gardens, London, SE1 8ND

Copyright © Legal Benchmarking Limited and its affiliated companies 2026

Accessibility | Terms of Use | Privacy Policy | Modern Slavery Statement

Armitage: “I am doing what I can” to keep Kappos at USPTO

armitage-45.jpg

Following an announcement that he will retire as Eli Lilly’s senior vice president and general counsel at the end of this year, Robert Armitage would not indicate whether he is interested in taking over as USPTO director, instead saying he is urging Kappos to stay on

armitage.jpg

Armitage has been a leading figure in patent law for over 30 years, and was actively involved in the creation and enactment of the AIA. He will be replaced by Michael Harrington, who has been promoted from vice president and deputy general counsel, global pharmaceutical operations at Eli Lilly, effective January 1 2013.

Although Armitage said he has not decided on next steps following his retirement, he is on the IP community’s list of potential Democratic party candidates to replace David Kappos as USPTO director. While Kappos may choose to stay on if President Barack Obama is re-elected, Managing IP sources have indicated he may want to leave.

When asked if he would consider the USPTO position, Armitage described Kappos as “a uniquely talented and able director”. He added: “I am doing what I can to urge him to continue in the role, to see many of the transformational changes in the USPTO to a successful conclusion.”



more from across site and SHARED ros bottom lb

More from across our site

News of Avanci hiring a senior vice president and the EPO teaming up with a French AI startup were also among the top talking points
Explosm, the independent Texas studio behind the hit webcomic Cyanide & Happiness, partnered with Temu’s IP protection team to combat counterfeiters infringing on its brand
The latest in a dispute over juicing machines, and a shakeup in judicial compositions were also among the top developments
Patent partner Robert Hollingshead explains why the firm remains committed to Japan despite several US firms exiting the Japanese and greater Asia market
Emma Green, partner at Bird & Bird, shares why the Iceland v Iceland dispute could prompt businesses and lawyers to think differently about brand enforcement
Attain IP, developed by two UK patent lawyers, will meet ‘forensic’ needs of patent attorneys by showing a verifiable reasoning chain, according to its co-founders
The High Court of Australia has allowed a fashion designer to retain her registered ‘Katie Perry’ trademark for clothing
Sim & San secured the win for Dr. Reddy’s, which will allow the pharma company to manufacture and export semaglutide, the active ingredient in Ozempic
Lucas Amodio joins our ‘Five minutes with’ series to discuss artificial intelligence systems and patent law
The Americas research cycle has commenced, so don't miss the opportunity to submit your work
Gift this article